Dr. Shao-Lee Lin discusses the new data presented at the EULAR 2019 that point to the systemic implications of uncontrolled gout & the need for treatment improvement.
INTERVIEWS
Monotherapy for patients with metastatic small cell lung cancer
Dr. Jonathan Cheng discusses the approval of KEYTRUDA as monotherapy for patients with metastatic small cell lung cancer.
A functional medicine approach to brain health
Dr. Krishna Doniparthi, Director and physician at Functional Medicine of Georgia discusses brain health on behalf of BodyBio, a world leader in fatty acid research.
Kidney disease & advancements in home dialysis care
Dr. Martin Schreiber, Chief Medical Officer for DaVita Home Dialysis, discusses kidney disease and the advancements in home dialysis care.
Cannabis technologies as a sleep aid and pain control
Dr. Levine discusses the scientifically-based cannabis technologies as aid for sleep disorder and pain control.
Marijuana unintended medical consequences
Dr. Crystal discusses marijuana unintended medical consequences & a new medicine to counteract cannabis-related overdoses.
Why the opioid crisis has become a fentanyl crisis
Dr. Crystal talks about why the opioid crisis has become a fentanyl crisis and an antidote to protect against a fentanyl attack.
Mild cognitive impairment signs & study
Dr. Scharre discusses the mild cognitive impairment (MC) signs and the latest study being conducted at OSU, Cornell & Rockefeller Neuroscience Center.
Reducing the progression of kidney disease in type 2 diabetes patients
Data from Farxiga Phase III DECLARE-TIMI 58 trial shows it significantly helped to reduce the progression of kidney disease in patients with type 2 diabetes.
Administering cannabidiol through nanotechnology for sports injuries treatment
Dr. Glenn Copeland, founder, chairman, and CEO of Copeland Biosciences discusses the company’s focus on nanotechnology to administer CBD (cannabidiol) in the treatment of sports injuries.